Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-05-05 @ 3:19 AM
Study NCT ID:
NCT00826358
Status:
COMPLETED
Last Update Posted:
2012-09-28
First Post:
2008-10-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
Sponsor:
AstraZeneca
Organization: